Skip to main content
SpringerLink
Log in

Is 1,25-dihydroxyvitamin D3 receptor expression a potential Achilles’ heel of CD44+ oral squamous cell carcinoma cells?

  • Original Research
  • Published:
Targeted Oncology Aims and scope Submit manuscript

An Erratum to this article was published on 26 July 2017

Abstract

The aim of this study was to analyse the expression of 1,25-dihydroxyvitamin D3 receptor (VDR) in oral cancers are squamous cell carcinomas (OSCC) to evaluate whether oral tissue may be a new potential target for biologically active 1,25-(OH)2D3 or its analogues. Expression of VDR was analysed in OSCC specimen (n = 191) and cancer cell lines (BICR3, BICR56) by immunohistochemistry, real-time polymerase chain reaction (RT-PCR) analysis, and Western blotting. Scanned images were digitally analysed using ImageJ and the immunomembrane plug-in. VDR expression on protein level was correlated with proliferation marker Ki-67, clinical characteristics and impact on survival. VDR was co-labelled with CD44 and Ki-67 in double labeling experiments. Expression subgroups were identified by receiver operating characteristics (ROC) analysis. Low VDR expression was significantly associated with recurrence of the tumour. Multivariate analysis demonstrated low VDR expression as an independent prognostic factor (p = 0.0005). Immunohistochemical double staining revealed VDR expression by CD44+ cancer cells. An inverse correlation of VDR+ expressing cancer cells with Ki-67 has been found, which was indicated by immunofluorescence double labeling. VDR specificity was confirmed by Western blot and RT-PCR analysis. For the first time, our study provides evidence that decreased VDR expression in OSCC might be associated with tumour relapse. Tumour cells of a putative CD44+ cancer stem cell compartment express VDR indicating a potential Achilles’ heel for the treatment of OSCC although, our results do not allow any conclusion on the function of VDR. Adjuvant chemoprevention by using 1,25-(OH)2D3 or its analogues can be a successful tool targeting adjuvant residual tumour cells and will likely help therapeutic optimization for cancer patients in the clinic. However, this hypothesis requires further in vitro and in vivo studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

OSCC:

Oral squamous cell carcinoma

HNSCC:

Head and neck squamous cell carcinoma

HE:

Hematoxylin and eosin

ROC:

Receiver operating characteristics analysis

AUC:

Area under the curve analysis

References

  1. Parkin DM, Laara E, Muir CS (1988) Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41(2):184–197

    Article  PubMed  CAS  Google Scholar 

  2. da Silva SD, Ferlito A, Takes RP, Brakenhoff RH, Valentin MD, Woolgar JA, Bradford CR, Rodrigo JP, Rinaldo A, Hier MP, Kowalski LP (2011) Advances and applications of oral cancer basic research. Oral Oncol 47(9):783–791. doi:10.1016/j.oraloncology.2011.07.004

    Article  PubMed  Google Scholar 

  3. Yu Y, Ramena G, Elble RC (2012) The role of cancer stem cells in relapse of solid tumours. Front Biosci (Elite Ed) 4:1528–1541

    Google Scholar 

  4. Dean M (2009) ABC transporters, drug resistance, and cancer stem cells. J Mammary Gland Biol Neoplasia 14(1):3–9. doi:10.1007/s10911-009-9109-9

    Article  PubMed  Google Scholar 

  5. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 104(3):973–978. doi:10.1073/pnas.0610117104

    Article  PubMed  CAS  Google Scholar 

  6. Zhang Z, Filho MS, Nor JE (2012) The biology of head and neck cancer stem cells. Oral Oncol 48(1):1–9. doi:10.1016/j.oraloncology.2011.10.004

    Article  PubMed  Google Scholar 

  7. Tobias JS (1990) Has chemotherapy proved itself in head and neck cancer? Br J Cancer 61(5):649–651

    Article  PubMed  CAS  Google Scholar 

  8. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, Giralt J, Maingon P, Rolland F, Bolla M, Cognetti F, Bourhis J, Kirkpatrick A, van Glabbeke M (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350(19):1945–1952. doi:10.1056/NEJMoa032641350/19/1945

    Article  PubMed  CAS  Google Scholar 

  9. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Machtay M, Ensley JF, Chao KS, Schultz CJ, Lee N, Fu KK (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350(19):1937–1944. doi:10.1056/NEJMoa032646350/19/1937

    Article  PubMed  Google Scholar 

  10. Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8(10):755–768. doi:10.1038/nrc2499

    Article  PubMed  CAS  Google Scholar 

  11. Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Paul O (1985) Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1(8424):307–309

    Article  PubMed  CAS  Google Scholar 

  12. Colston K, Colston MJ, Feldman D (1981) 1,25-Dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology 108(3):1083–1086

    Article  PubMed  CAS  Google Scholar 

  13. Abe E, Miyaura C, Sakagami H, Takeda M, Konno K, Yamazaki T, Yoshiki S, Suda T (1981) Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A 78(8):4990–4994

    Article  PubMed  CAS  Google Scholar 

  14. Palmer HG, Gonzalez-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, Quintanilla M, Cano A, de Herreros AG, Lafarga M, Munoz A (2001) Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 154(2):369–387

    Article  PubMed  CAS  Google Scholar 

  15. Vink-van Wijngaarden T, Pols HA, Buurman CJ, Birkenhager JC, van Leeuwen JP (1996) Inhibition of insulin- and insulin-like growth factor-I-stimulated growth of human breast cancer cells by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogue EB1089. Eur J Cancer 32A(5):842–848

    Article  PubMed  CAS  Google Scholar 

  16. Park WH, Seol JG, Kim ES, Jung CW, Lee CC, Binderup L, Koeffler HP, Kim BK, Lee YY (2000) Cell cycle arrest induced by the vitamin D(3) analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27. Exp Cell Res 254(2):279–286. doi:10.1006/excr.1999.4735

    Article  PubMed  CAS  Google Scholar 

  17. Skowronski RJ, Peehl DM, Feldman D (1993) Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. Endocrinology 132(5):1952–1960

    Article  PubMed  CAS  Google Scholar 

  18. Kornfehl J, Formanek M, Temmel A, Knerer B, Willheim M (1996) Antiproliferative effects of the biologically active metabolite of vitamin D3 (1,25 [OH]2D3) on head and neck squamous cell carcinoma cell lines. Eur Arch Otorhinolaryngol: Off J Eur Fed Otorhinolaryngol Soc 253(6):341–344

    CAS  Google Scholar 

  19. Meier JD, Enepekides DJ, Poirier B, Bradley CA, Albala JS, Farwell DG (2007) Treatment with 1-alpha,25-dihydroxyvitamin D3 (vitamin D3) to inhibit carcinogenesis in the hamster buccal pouch model. Arch Otolaryngol Head Neck Surg 133(11):1149–1152. doi:10.1001/archotol.133.11.1149

    Article  PubMed  Google Scholar 

  20. Kulbersh JS, Day TA, Gillespie MB, Young MR (2009) 1alpha,25-Dihydroxyvitamin D(3) to skew intratumoural levels of immune inhibitory CD34(+) progenitor cells into dendritic cells. Otolaryngol Head Neck Surg: Off J Am Acad Otolaryngol Head Neck Surg 140(2):235–240. doi:10.1016/j.otohns.2008.11.011

    Article  Google Scholar 

  21. Young MR, Wright MA, Lozano Y, Prechel MM, Benefield J, Leonetti JP, Collins SL, Petruzzelli GJ (1997) Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells. Int J Cancer J Inter du Cancer 74(1):69–74

    Article  CAS  Google Scholar 

  22. Lu L, Qiu J, Liu S, Luo W (2008) Vitamin D3 analogue EB1089 inhibits the proliferation of human laryngeal squamous carcinoma cells via p57. Mol Cancer Ther 7(5):1268–1274. doi:10.1158/1535-7163.MCT-07-2222

    Article  PubMed  CAS  Google Scholar 

  23. Hager G, Kornfehl J, Knerer B, Weigel G, Formanek M (2004) Molecular analysis of p21 promoter activity isolated from squamous carcinoma cell lines of the head and neck under the influence of 1,25(OH)2 vitamin D3 and its analogs. Acta Otolaryngol 124(1):90–96

    Article  PubMed  Google Scholar 

  24. Satake K, Takagi E, Ishii A, Kato Y, Imagawa Y, Kimura Y, Tsukuda M (2003) Anti-tumour effect of vitamin A and D on head and neck squamous cell carcinoma. Auris, nasus, larynx 30(4):403–412

    Article  PubMed  Google Scholar 

  25. Prudencio J, Akutsu N, Benlimame N, Wang T, Bastien Y, Lin R, Black MJ, Alaoui-Jamali MA, White JH (2001) Action of low calcemic 1alpha,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma. Journal of the National Cancer Institute 93(10):745–753

    Article  PubMed  CAS  Google Scholar 

  26. So JY, Lee HJ, Smolarek AK, Paul S, Wang CX, Maehr H, Uskokovic M, Zheng X, Conney AH, Cai L, Liu F, Suh N A novel Gemini vitamin D analog represses the expression of a stem cell marker CD44 in breast cancer. Mol Pharmacol. doi:10.1124/mol.110.068403

  27. Kumagai T, O'Kelly J, Said JW, Koeffler HP (2003) Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumour activity against leukemia, myeloma, and colon cancer cells. J Natl Cancer Inst 95(12):896–905

    Article  PubMed  CAS  Google Scholar 

  28. Sobin LH, Wittekind CH (2010) UICC. TNM classification of malignant tumours, 7th edn. Springer Verlag, Berlin

    Google Scholar 

  29. Hamilton SR, Aaltonen LA (2000) Pathology and Ggenetics. Tumours of the digestive system, 3rd edn. IARC Press, Lyon

    Google Scholar 

  30. von Rahden BH, Kircher S, Kafka M, Stuermer L, Reiber C, Gattenlohner S, Germer CT, Grimm M (2010) Glucocorticoid-induced TNFR family-related receptor (GITR)-expression in tumour infiltrating leucocytes (TILs) is associated with the pathogenesis of esophageal adenocarcinomas with and without Barrett’s mucosa. Canc Biomarkers: Sec A Dis Markers 7(6):285–294. doi:10.3233/CBM-2010-0192

    Google Scholar 

  31. Grimm M, Lazariotou M, Kircher S, Stuermer L, Reiber C, Hofelmayr A, Gattenlohner S, Otto C, Germer CT, von Rahden BH (2010) MMP-1 is a (pre-)invasive factor in Barrett-associated esophageal adenocarcinomas and is associated with positive lymph node status. J Transl Med 8:99. doi:10.1186/1479-5876-8-99

    Article  PubMed  Google Scholar 

  32. Alexander D, Hoffmann J, Munz A, Friedrich B, Geis-Gerstorfer J, Reinert S (2008) Analysis of OPLA scaffolds for bone engineering constructs using human jaw periosteal cells. J Mater Sci Mater Med 19(3):965–974. doi:10.1007/s10856-007-3351-8

    Article  PubMed  CAS  Google Scholar 

  33. Alexander D, Schafer F, Olbrich M, Friedrich B, Buhring HJ, Hoffmann J, Reinert S (2010) MSCA-1/TNAP selection of human jaw periosteal cells improves their mineralization capacity. Cell Physiol Biochem 26(6):1073–1080. doi:10.1159/000323985

    Article  PubMed  CAS  Google Scholar 

  34. Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39(4):561–577

    PubMed  CAS  Google Scholar 

  35. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 75:457–487

    Article  Google Scholar 

  36. Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50(3):163–170

    PubMed  CAS  Google Scholar 

  37. Cox DR (1972) Regression models and life tables. J R Stat Soc 34:1987–2001

    Google Scholar 

  38. Reichrath J, Rafi L, Muller SM, Mink D, Reitnauer K, Tilgen W, Schmidt W, Friedrich M (1998) Immunohistochemical analysis of 1,25-dihydroxyvitamin D3 receptor in cervical carcinoma. Histochem J 30(8):561–567

    Article  PubMed  CAS  Google Scholar 

  39. Mack B, Gires O (2008) CD44s and CD44v6 expression in head and neck epithelia. PLoS One 3(10):e3360. doi:10.1371/journal.pone.0003360

    Article  PubMed  Google Scholar 

  40. Harper LJ, Costea DE, Gammon L, Fazil B, Biddle A, Mackenzie IC (2010) Normal and malignant epithelial cells with stem-like properties have an extended G2 cell cycle phase that is associated with apoptotic resistance. BMC Cancer 10:166. doi:10.1186/1471-2407-10-166

    Article  PubMed  Google Scholar 

  41. Mackenzie IC (2004) Growth of malignant oral epithelial stem cells after seeding into organotypical cultures of normal mucosa. J Oral Pathol Med: Official Publ Int Assoc J Oral Pathol Am Acad Oral Pathol 33(2):71–78

    Article  Google Scholar 

  42. Richard V, Pillai MR (2010) The stem cell code in oral epithelial tumourigenesis: ‘the cancer stem cell shift hypothesis’. Biochim Biophys Acta 1806(2):146–162. doi:10.1016/j.bbcan.2010.06.004

    PubMed  CAS  Google Scholar 

  43. Zeljic K, Supic G, Stamenkovic Radak M, Jovic N, Kozomara R, Magic Z (2012) Vitamin D receptor, CYP27B1 and CYP24A1 genes polymorphisms association with oral cancer risk and survival. J Oral Pathol Med Off Pub Int Assoc Oral Pathol Am Acad Oral Pathol. doi:10.1111/j.1600-0714.2012.01164.x

  44. Costa EM, Feldman D (1987) Measurement of 1,25-dihydroxyvitamin D3 receptor turnover by dense amino acid labeling: changes during receptor up-regulation by vitamin D metabolites. Endocrinology 120(3):1173–1178

    Article  PubMed  CAS  Google Scholar 

  45. Wiese RJ, Uhland-Smith A, Ross TK, Prahl JM, DeLuca HF (1992) Up-regulation of the vitamin D receptor in response to 1,25-dihydroxyvitamin D3 results from ligand-induced stabilization. J Biol Chem 267(28):20082–20086

    PubMed  CAS  Google Scholar 

  46. Mangelsdorf DJ, Pike JW, Haussler MR (1987) Avian and mammalian receptors for 1,25-dihydroxyvitamin D3: in vitro translation to characterize size and hormone-dependent regulation. Proc Natl Acad Sci U S A 84(2):354–358

    Article  PubMed  CAS  Google Scholar 

  47. Lehmann B (1997) HaCaT cell line as a model system for vitamin D3 metabolism in human skin. J Investig Dermatol 108(1):78–82

    Article  PubMed  CAS  Google Scholar 

  48. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, Demay M (2008) Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 29(6):726–776. doi:10.1210/er.2008-0004

    Article  PubMed  CAS  Google Scholar 

  49. Pillai S, Bikle DD, Elias PM (1988) 1,25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation. J Biol Chem 263(11):5390–5395

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Julia Fertinger, Mohammed Saleh, and Besher Shokri for their technical assistance.

Conflict of interests

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

  1. Department of Oral and Maxillofacial Surgery, University Hospital Tuebingen, Osianderstrasse 2-8, 72076, Tuebingen, Germany

    Martin Grimm, Dorothea Alexander, Adelheid Munz, Juergen Hoffmann & Siegmar Reinert

  2. Department of Oral and Maxillofacial Surgery, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany

    Juergen Hoffmann

Authors
  1. Martin Grimm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dorothea Alexander
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Adelheid Munz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Juergen Hoffmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Siegmar Reinert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martin Grimm.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/s11523-017-0523-4.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grimm, M., Alexander, D., Munz, A. et al. Is 1,25-dihydroxyvitamin D3 receptor expression a potential Achilles’ heel of CD44+ oral squamous cell carcinoma cells?. Targ Oncol 8, 189–201 (2013). https://doi.org/10.1007/s11523-013-0255-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11523-013-0255-z

Keywords

Search

Navigation